Back to Centiva Capital, LP Centiva Capital, LP

MRNAMRNA

Showing 6 of 22 quarters

Position history for Centiva Capital, LPCentiva Capital, LP's holdings in Moderna, Inc.

No. Centiva Capital exited its MRNA (Moderna) position in Q2 2026. Its Q1 2026 13F listed 2,733 shares worth $138,836. Centiva Capital first reported MRNA in Q2 2020 and held it in 15 quarterly 13F filings.

Final Value

$0

Final Shares

0

Total Value Change

-$305,279

Total Shares Change

-4,568

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Exited
0
-100.0%
$00.0%$70.03
0
2026-Q1
New
2,733
—
$138,8360.0%$50.80
31
2025-Q3
Exited
0
-100.0%
$00.0%$25.83
0
2025-Q2
New
6,311
—
$174,1200.0%$27.59
31
2024-Q4
Exited
0
-100.0%
$00.0%$41.58
0
2024-Q3
Decreased
4,568
-0.1%
$305,2790.0%$65.75
0

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used